Amerisafe (AMSF) director receives 2,340-share stock grant award

Rhea-AI Filing Summary

Roach Randy reported acquisition or exercise transactions in this Form 4 filing.

AMERISAFE INC director Randy Roach received a stock grant of 2,340 shares of common stock on June 10, 2026, at no cash cost per share. These shares are subject to restrictions that lapse at the company’s 2027 annual meeting of shareholders. After the grant, Roach directly holds 18,862 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Roach Randy

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.01	2,340	$0.00	--

Holdings After Transaction: Common stock, par value $0.01 — 18,862 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 2,340 shares Grant price per share: $0.00 per share Total holdings after grant: 18,862 shares +2 more

5 metrics

Shares granted 2,340 shares Director stock grant on June 10, 2026

Grant price per share $0.00 per share Equity compensation award, not market purchase

Total holdings after grant 18,862 shares Director’s direct ownership following transaction

Transaction code A (Grant, award, or other acquisition) Non-derivative equity award

Restriction lapse 2027 annual meeting of shareholders Vesting/transfer restrictions end point

Key Terms

Grant, award, or other acquisition, Common stock, par value $0.01, annual meeting of shareholders

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common stock, par value $0.01 financial

"security_title: Common stock, par value $0.01"

annual meeting of shareholders regulatory

"restrictions that will lapse at the time of the Issuer's 2027 annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roach Randy

(Last) (First) (Middle)

2301 HIGHWAY 190 WEST

(Street)

DERIDDER LOUISIANA 70634

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMERISAFE INC [ AMSF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.01	06/10/2026		A		2,340(1)	A	$0	18,862	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Subject to restrictions that will lapse at the time of the Issuer's 2027 annual meeting of shareholders.

	/s/ Kathryn H. Shirley, attorney-in-fact for Randall Roach	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AMERISAFE (AMSF) director Randy Roach report?

Randy Roach reported receiving a grant of 2,340 shares of AMERISAFE common stock. The transaction is coded as a grant or award, meaning it is compensation-related rather than an open-market purchase or sale, and does not involve cash paid by the director.

At what price were the 2,340 AMERISAFE (AMSF) shares granted to the director?

The 2,340 AMERISAFE shares were granted at a reported price of $0.00 per share. This reflects a stock-based compensation award, where the director receives equity directly instead of buying shares on the open market for cash consideration.

What restrictions apply to Randy Roach’s new AMERISAFE (AMSF) share grant?

The footnote states the granted shares are subject to restrictions that will lapse at AMERISAFE’s 2027 annual meeting of shareholders. Until then, the shares are restricted, aligning vesting or transferability with that future shareholder meeting timeline.

How many AMERISAFE (AMSF) shares does Randy Roach own after this Form 4 transaction?

Following the grant, Randy Roach directly holds 18,862 AMERISAFE common shares. This total includes the newly awarded 2,340 shares and reflects his direct ownership position reported as of the transaction date in the Form 4 filing.

Does this AMERISAFE (AMSF) Form 4 show a director buying or selling shares on the market?

No, the Form 4 reports a grant or award acquisition, coded “A,” not an open-market buy or sell. The director received 2,340 shares as equity compensation, with no market trade or cash price involved in the reported transaction.